Correction to: Cell Death Discovery https://doi.org/10.1038/s41420-021-00747-y, published online 18 November 2021
The original version of this article unfortunately contained a mistake. There were errors in Figs. 2b, 5b and 5d. The authors apologize for the error. The original article has been corrected.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Lu, Y., Shen, H., Huang, W. et al. Correction: Genome-scale CRISPR-Cas9 knockout screening in hepatocellular carcinoma with lenvatinib resistance. Cell Death Discov. 8, 74 (2022). https://doi.org/10.1038/s41420-022-00836-6
Published:
DOI: https://doi.org/10.1038/s41420-022-00836-6
